Aevi Genomic Medicine Reports Third Quarter 2017 Financial Results

Go back to Aevi Genomic Medicine Reports Third Quarter 2017 Financial Results
(NYSE: GNMX) Delayed: 35.13 -0.71 (1.98%)
Previous Close $35.84    52 Week High
Open $35.13    52 Week Low
Day High $35.13    P/E N/A 
Day Low $35.11    EPS
Volume 440